Invivyd cover photo
Invivyd

Invivyd

生物技术研究

Waltham,Massachusetts 12,653 位关注者

Invivyd creates medicines that are more potent and resistant to virus evolution than the human immune system.

关于我们

Invivyd, Inc. (Nasdaq: IVVD) creates medicines that are more potent and resistant to virus evolution than the human immune system. We deploy a proprietary integrated technology platform unique in the industry to assess, monitor, drug and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more. #covid19 #immunocompromised

网站
https://www.invivyd.com
所属行业
生物技术研究
规模
51-200 人
总部
Waltham,Massachusetts
类型
上市公司
创立
2020

地点

  • 主要

    1601 Trapelo Rd

    Suite 178

    US,Massachusetts,Waltham,02451

    获取路线

Invivyd员工

动态

相似主页

查看职位

融资